Will Aptevo Therapeutics (APVO) reach $49 in the next year
What’s up with Aptevo Therapeutics?
Aptevo Therapeutics (APVO) opened at $5.26, which means the stock is up 28.20% from yesterday’s closing price of 5.04. Today, the company has a high of $6.47 and a low of $5.19. The company has a market cap of $20.34 with a 52-week high of $14.56 and a 52-week low of $0.27.
What about the future for Aptevo Therapeutics?
The high forecast for Aptevo Therapeutics is 49.00 while the low is 24.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Aptevo Therapeutics has a strong forecast. A strong forecast is a result of strong earning reports as investors are willing to pay a higher share price today because of growth expectations in the future. Based on this information APVO seems to be a safe buy.
About Aptevo Therapeutics
Aptevo Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, commercialization, and sale of novel oncology and hematology therapeutics to improve patients lives. Its pipeline includes APVO210, APVO436, ROR1 Candidate, and ALG.APV-527. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.